Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.

A. Benard; A.I. van Sighem; A. Taieb; E. Valadas; J.-L. Ruelle; V. Soriano; A. Calmy; C. Balotta; F. Damond; F. Brun-Vezinet; G. Chene; I.M. Hoepelman; S.P.M. Geelen; X et al.; S. Matheron

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.

Translated title of the contribution: Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.

A. Benard, A.I. van Sighem, A. Taieb, E. Valadas, J.-L. Ruelle, V. Soriano, A. Calmy, C. Balotta, F. Damond, F. Brun-Vezinet, G. Chene, I.M. Hoepelman, S.P.M. Geelen, X et al., S. Matheron

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.
Original language	Undefined/Unknown
Pages (from-to)	1257-1266
Number of pages	10
Journal	Clinical Infectious Diseases
Volume	52
Issue number	10
Publication status	Published - 2011

Cite this

Benard, A., van Sighem, A. I., Taieb, A., Valadas, E., Ruelle, J.-L., Soriano, V., Calmy, A., Balotta, C., Damond, F., Brun-Vezinet, F., Chene, G., Hoepelman, I. M., Geelen, S. P. M., et al., X., & Matheron, S. (2011). Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group. Clinical Infectious Diseases, 52(10), 1257-1266.

@article{a1d27398299d4a05b027b36bd463dac3,

title = "Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.",

author = "A. Benard and {van Sighem}, A.I. and A. Taieb and E. Valadas and J.-L. Ruelle and V. Soriano and A. Calmy and C. Balotta and F. Damond and F. Brun-Vezinet and G. Chene and I.M. Hoepelman and S.P.M. Geelen and {et al.}, X and S. Matheron",

year = "2011",

language = "Undefined/Unknown",

volume = "52",

pages = "1257--1266",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "10",

}

Benard, A, van Sighem, AI, Taieb, A, Valadas, E, Ruelle, J-L, Soriano, V, Calmy, A, Balotta, C, Damond, F, Brun-Vezinet, F, Chene, G, Hoepelman, IM , Geelen, SPM, et al., X & Matheron, S 2011, 'Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.', Clinical Infectious Diseases, vol. 52, no. 10, pp. 1257-1266.

Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group. / Benard, A.; van Sighem, A.I.; Taieb, A. et al.
In: Clinical Infectious Diseases, Vol. 52, No. 10, 2011, p. 1257-1266.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group.

AU - Benard, A.

AU - van Sighem, A.I.

AU - Taieb, A.

AU - Valadas, E.

AU - Ruelle, J.-L.

AU - Soriano, V.

AU - Calmy, A.

AU - Balotta, C.

AU - Damond, F.

AU - Brun-Vezinet, F.

AU - Chene, G.

AU - Hoepelman, I.M.

AU - Geelen, S.P.M.

AU - et al., X

AU - Matheron, S.

PY - 2011

Y1 - 2011

M3 - Article

SN - 1058-4838

VL - 52

SP - 1257

EP - 1266

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 10

ER -